Centers | ||
|
|
|
Collaborative Drug Discovery, Inc. | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | Therapeutic Accelerator Program (TAP) |
Chemical registration system Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis. |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
Test |
Partnerships |
Events |
Jobs |
Cerecor Partners with Johns Hopkins Brain Science Institute to Treat SchizophreniaCerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns... View all Research Collaboration and license agreementThe Drug Discovery Unit announces a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including... View all TB Drug Accelerator
View all |
No EVENTS for listing |
No Job Posts |
